Chronic hepatitis B is expected to be completely cured
ADC评论
November 10, 2022
On November 8, GlaxoSmithKline (GSK) announced that the phase IIb clinical results of the antisense oligonucleotide bepirovirsen in the treatment of chronic hepatitis B will
